Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The Chinese-German Journal of Clinical Oncology
Metadata
Title
The expression and significance of cyclin B1 and survivin in human non-small cell lung cancer
Authors
Guosheng Li
Xuhan Liu
Daorong Zhang
Dong Liu
Zhiyong Li
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
The Chinese-German Journal of Clinical Oncology / Issue 4/2011
Print ISSN: 1610-1979
Electronic ISSN: 1613-9089
DOI
https://doi.org/10.1007/s10330-011-0771-1

Other articles of this Issue 4/2011

The Chinese-German Journal of Clinical Oncology 4/2011 Go to the issue

OriginalPaper

HSP27: a candidate differentially expressed protein between left- and right-sided colon carcinomas

OriginalPaper

Expression and clinical significance of MN1 and PTEN gene in patients with acute myeloid leukemia

OriginalPaper

Silencing Sp1 suppresses telomerase activity and promotes apoptosis of SW480 cells line in colorectal carcinoma

OriginalPaper

No hot, no watery, no sweet, give correct food to patients receiving chemotherapy

OriginalPaper

Prospective clinical studies at the efficacy of brucea javanica oil, mitomycin and BCG for preventing postoperative relapse of superficial bladder cancer through perfusion

OriginalPaper

Effect of endobronchial blocker tube in the pulmonary carcinoma with video-assisted thoracic surgery
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits